Since arterial hypertension has been repeatedly reported as a primary manifestation of mitochondrial disorders (MIDs) [3], it is conceivable that arterial hypertension in patient-1 as well as patient-3 was a primary phenotypic manifestation of the NDUFAF5 mutation. This evidence concerns the gene NDUFAF5 and Hypertension.